Gapping up
In reaction to strong earnings/guidance:
- AA +4.1%, PAG +2.9%, WNS +1.9%, OI +1.2%, DPZ +0.6%
Other news:
- ACIU +78.3% (announced the initiation of the second highest dosing group in the Company's Phase 1b/2a clinical trial evaluating ACI-35.030 for the treatment of Alzheimer's disease)
- LCI +36.2% (Lannett and Cediprof announce exclusive distribution agreement for an approved levothyroxine; to commence marketing on August 3, 2020)
- DELL +10.4% (Dell confirms it's exploring a potential spin-off of VMW stake)
- KNSA +5.9% (receives Orphan Drug designation for rilonacept for the treatment of pericarditis from the FDA)
- RTIX +5.3% (receives all necessary approvals for sale of OEM business)
- GAN +4.7% (reports June 2020 Internet gambling update for NJ)
- SPCE +3.1% (names new CEO)
- VXX +2.8% (rising with futures trading lower)
- DKNG +2.1% (launches Casino product suite in West Virginia)
- CDXC +1.4% (announces new preclinical study finds Niagen corrects social deficits in mouse model of autism)
Analyst comments:
- NXTC +5.4% (upgraded to Buy from Hold at The Benchmark Company)
- GLW +1.8% (upgraded to Overweight from Neutral at JP Morgan)
- PTC +1.5% (upgraded to Buy from Hold at Stifel)
- NRZ +1.4% (upgraded to Overweight from Neutral at Piper Sandler)
- UGI +0.7% (upgraded to Equal Weight from Underweight at Barclays)